Bromide

Bromide

SCHEMBL7424338

Br.O=C(NC(Cc1nc2ccccc2o1)C(=O)O)OCc1ccccc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.47
▸ ITGB3 P05106 5/20 0.47
▸ ITGA2B P08514 4/20 0.47
▸ TACR1 P25103 3/20 0.47
▸ ITGAV P06756 1/20 0.46
▸ CTSL P07711 2/20 0.46
▸ CTSB P07858 2/20 0.46
▸ CTSS P25774 2/20 0.46
▸ PRSS1 P07477 1/20 0.46
▸ PRSS2 P07478 1/20 0.46
▸ PRSS3 P35030 1/20 0.46
▸ TPSAB1 Q15661 1/20 0.46
▸ TYR P14679 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6495999 0.90 ALDH1A1 (0.51) ATMTACR1CTSLCTSBCTSS
SCHEMBL7168299 0.81 ITGB3 (0.59) ITGB3ITGA2BITGAV
SCHEMBL7168302 0.81 ITGB3 (0.59) ITGB3ITGA2BITGAV
SCHEMBL20526765 0.80 MDM4 (0.52) —
SCHEMBL20526762 0.80 MDM4 (0.52) —
SCHEMBL32676378 0.80 MDM4 (0.52) —
SCHEMBL25298238 0.80 TNKS (0.51) ATM
SCHEMBL5392224 0.79 ITGB3 (0.49) ITGB3ITGA2BTACR1ITGAVCTSL
SCHEMBL5392233 0.79 ITGB3 (0.49) ITGB3ITGA2BTACR1ITGAVCTSL
SCHEMBL479010 0.78 TACR1 (0.68) ITGB3ITGA2BTACR1CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815103-A1 TRYPSIN AND THROMBIN INHIBITORS Novartis AG (CH) 1998-01-07 — — EP disclosed
WO-1996029327-A1 TRYPSIN AND THROMBIN INHIBITORS NOVARTIS AG (CH) 1996-09-26 — — WO disclosed
Send feedback